MGAT4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.347800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.325400E-01
Normal-vs-Stage2
6.744000E-02
Normal-vs-Stage3
3.544300E-02
Normal-vs-Stage4
2.055000E-01
Stage1-vs-Stage2
9.980000E-01
Stage1-vs-Stage3
3.424400E-01
Stage1-vs-Stage4
8.755400E-01
Stage2-vs-Stage3
1.912220E-01
Stage2-vs-Stage4
8.094600E-01
Stage3-vs-Stage4
4.144000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.075150E-01
Normal-vs-AfricanAmerican
3.752000E-01
Normal-vs-Asian
6.299000E-03
Caucasian-vs-AfricanAmerican
4.133200E-01
Caucasian-vs-Asian
5.295900E-02
AfricanAmerican-vs-Asian
2.436100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.066300E-02
Normal-vs-Female
1.547190E-01
Male-vs-Female
5.659200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.429800E-01
Normal-vs-Age(41-60Yrs)
2.058800E-01
Normal-vs-Age(61-80Yrs)
7.991700E-02
Normal-vs-Age(81-100Yrs)
2.040000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.467800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.083000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.420200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.661900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.629900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.517850E-02
Normal-vs-Daily Drinker
1.068330E-02
Normal-vs-Weekly Drinker
1.251980E-02
Normal-vs-Occasional Drinker
4.626400E-01
Normal-vs-Social Drinker
1.513780E-01
Non Drinker-vs-Daily Drinker
5.189000E-01
Non Drinker-vs-Weekly Drinker
6.372000E-01
Non Drinker-vs-Occasional Drinker
2.837200E-01
Non Drinker-vs-Social Drinker
5.385200E-01
Daily Drinker-vs-Weekly Drinker
9.176400E-01
Daily Drinker-vs-Occasional Drinker
1.732830E-01
Daily Drinker-vs-Social Drinker
3.114600E-01
Weekly Drinker-vs-Occasional Drinker
1.993650E-01
Weekly Drinker-vs-Social Drinker
4.081200E-01
Occasional Drinker-vs-Social Drinker
5.761000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.586800E-01
Normal-vs-Grade 2
5.862800E-01
Normal-vs-Grade 3
4.990200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.958400E-01
Grade 1-vs-Grade 3
6.908800E-01
Grade 1-vs-Grade 4
5.586800E-01
Grade 2-vs-Grade 3
4.960000E-01
Grade 2-vs-Grade 4
5.862800E-01
Grade 3-vs-Grade 4
4.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.519900E-03
Normal-vs-NonDiabetic
6.477900E-02
Diabetic-vs-NonDiabetic
8.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.135090E-03
Normal-vs-NoPancreatitis
6.661600E-02
Pancreatitis-vs-NoPancreatitis
6.917700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.735240E-01
Normal-vs-N1
7.271800E-02
N0-vs-N1
7.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.139600E-02
Normal-vs-TP53-NonMutant
3.518800E-01
TP53-Mutant-vs-TP53-NonMutant
9.555600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
